Gemini Therapeutics, Inc. (GMTX) Social Stream
GEMINI THERAPEUTICS INC (GMTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering GMTX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 3 | $25 | $20 | $22.666 | $1.35 | 1578.96% |
| 2021-11-19 | 3 | $25 | $11 | $19.666 | $1.35 | 1356.74% |
| 2021-12-15 | 4 | $25 | $11 | $19.75 | $1.35 | 1362.96% |
| 2021-12-20 | 4 | $23 | $11 | $17.25 | $1.35 | 1177.78% |
| 2022-01-24 | 4 | $23 | $10 | $16 | $1.35 | 1085.19% |
| 2022-03-01 | 1 | $1.5 | $1.5 | $1.5 | $1.35 | 11.11% |
| 2022-03-03 | 3 | $11 | $1.5 | $4.875 | $1.35 | 261.11% |
| 2022-03-11 | 2 | $2 | $1.5 | $1.75 | $1.35 | 29.63% |
| 2022-07-11 | 4 | $11 | $1.5 | $4.125 | $1.35 | 205.56% |
Over the past 168 days, GMTX's average upside potential has been 232.2%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-24 | 3 | 23 | 10.0 | 16.000 | 2.000 | 700% |
| 2022-03-01 | 3 | 11 | 1.5 | 6.875 | 1.295 | 430.89% |
| 2022-03-11 | 4 | 2 | 1.5 | 1.750 | 1.500 | 16.67% |
| 2022-03-11 | 3 | 2 | 1.5 | 1.750 | 1.500 | 16.67% |
| 2022-07-11 | 4 | 11 | 1.5 | 4.125 | 1.660 | 148.49% |
GMTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.5 | 1 | 0 | 3 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 39 weeks, GMTX's average broker recommendation rating worsened by 1.5.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- GMTX has a higher number of analysts covering the stock than 148.36% of all US stocks.
- GMTX has a higher upside potential (average analyst target price relative to current price) than 1186.57% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, GEMINI THERAPEUTICS INC's average analyst price target is higher than 180.65% of them.
- In the context of stocks in the small market cap category, GEMINI THERAPEUTICS INC's variance in analysts' estimates is lower than -906.27% of them.
Stocks similar to GEMINI THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TNGX, DYN, and CMPS.
View All Top Stocks by Price Target
Make investment decisions regarding GMTX using the data that counts. Try POWR Ratings for free.